To amend the Federal Food, Drug, and Cosmetic Act to require that each prescription drug sold at retail bear a label that states the full retail price of the drug.

December 8, 2003

Ms. HOOLEY of Oregon introduced the following bill; which was referred to the Committee on Energy and Commerce

To amend the Federal Food, Drug, and Cosmetic Act to require that each prescription drug sold at retail bear a label that states the full retail price of the drug.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the `Prescription Drug Retail Price Disclosure Act'.

SEC. 2. FEDERAL FOOD, DRUG, AND COSMETIC ACT; REQUIREMENT OF LABEL STATING FULL RETAIL PRICE OF PRESCRIPTION DRUGS.

Section 502 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352) is amended by adding at the end the following:

`(w) If it is a drug subject to section 503(b) and is sold at retail without bearing a label that states the full retail price for the drug, which price is the retail price that applies in the absence of--

`(1) any discount;

`(2) any payment for the drug under an insurance policy or by an entity that provides health services on a pre-paid basis; and

`(3) any payment for the drug under a Federal or State health benefits program or a State compensation program.'.

END